SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11990)12/2/1997 4:45:00 PM
From: Andrew H  Read Replies (1) | Respond to of 32384
 
>>Now they have Phase II data in Europe, so its probably easy to begin at Phase III for CTCL.<<

Henry, I thought P 11/111 trials were well underway and they would be applying for an NDA for CTCL in 2nd half of 98.

Perhaps they are expanding because they need more numbers? CTCL population is pretty small.



To: Henry Niman who wrote (11990)12/2/1997 5:44:00 PM
From: Hippieslayer  Respond to of 32384
 
Call me French. I completely forgot that drugs do have a market outside of the USA and that Europe would rather save lives than tie up drug companies like we do here.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News